Beyond the Pillbox: Using HOPE to Deliver Holistic, Compassionate Hospice Care

Written By Michelle Horner, Manager, Clinical Consulting & Education, McBee

Managing pain and preventing suffering are fundamental to hospice care—but our responsibilities as clinicians go far beyond handing out medications. Hospice is about meeting patients where they are, understanding the full impact of their symptoms and designing care plans that are both clinically effective and deeply compassionate. The new HOPE (Hospice Outcomes and Patient Evaluation) assessment tool gives hospice teams a powerful way to accomplish this.

In our recent webinar, Beyond the Pillbox: HOPE, Hospice Meds & Symptom Monitoring, we focused on how Section N of the HOPE assessment can be leveraged to improve symptom control and enhance quality of life at the end of life. This section collects data on scheduled and PRN opioid use, as well as whether a prophylactic bowel regimen is in place to help prevent opioid-induced constipation. These may seem like small details—but they tell a big story about how well a patient’s pain is being managed, how proactive our care is and how engaged we are in anticipating their needs.

Holistic care starts with holistic assessment

One of the most valuable aspects of the HOPE tool is that it doesn’t just ask what medications are being used, but if they’re effective, and how symptoms are impacting a patient’s ability to function and engage with life. It invites us to look at the full picture—pain, non-pain symptoms, emotional and functional burden—and design care plans that reflect the reality of the patient’s lived experience.

HOPE also reinforces the need for timely follow-up. Medicare is introducing two new quality measures—Timely Follow-Up for Pain Impact and Timely Follow-Up for Non-Pain Symptom Impact—that will hold providers accountable for how quickly they respond when a patient reports distressing symptoms with a severity of moderate or severe. These measures are part of a broader shift toward data-informed, patient-centered hospice care. They send a clear message: we must not only assess symptoms accurately, but act on them quickly and effectively.

From assessment to action

Assessment without follow-through is not enough. That’s why this webinar also tied HOPE guidance directly to the Hospice Conditions of Participation (CoPs) related to medication management and symptom control. It’s one thing to know what the patient is feeling—it’s another to show that you’ve done something about it.

We discussed best practices for translating HOPE data into meaningful care planning. That means:

• Implementing opioid regimens with appropriate bowel prophylaxis
• Documenting effectiveness of treatments
• Tracking changes in symptom impact over time
• Aligning interdisciplinary care plans with patient-centered goals

All of this supports not only regulatory compliance but also the delivery of high-quality, whole-person care—something every hospice professional strives for.

What’s next?

If you missed the live session, don’t worry. You can still catch the full webinar recording to get practical documentation tips, insight into CMS’s evolving quality landscape and a fresh perspective on how HOPE can be more than a requirement—it can be a catalyst for truly compassionate care.

Click here to listen to our recent webinar on Section N of the HOPE assessment.